Koyfin Home > Directory > Health Care > Nymox Pharm Corp > EV / EBITDA (ntm)

Nymox Pharm Corp EV / EBITDA (ntm) Chart (NYMX)

Nymox Pharm Corp annual/quarterly EV / EBITDA (ntm) from 2013 to 2013. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Nymox Pharm Corp EV / EBITDA (ntm) for the quarter ending August 08, 2013 was 44.48 a 2.18% increase of 0.97 year over year
  • Nymox Pharm Corp EV / EBITDA (ntm) for the last 12 months ending August 08, 2013 was 44.48 a 2.18% increase of 0.97 year over year
  • Nymox Pharm Corp Annual EV / EBITDA (ntm) for 2013 was 44.48 a -0.77% decrease of -0.34 from 2012
  • Nymox Pharm Corp Annual EV / EBITDA (ntm) for 2013 was 44.82 a 1.91% increase of 0.86 from 2012
  • Nymox Pharm Corp Annual EV / EBITDA (ntm) for 2013 was 43.96 a 1.04% increase of 0.46 from 2012
Other Valuation Metrics:
  • Nymox Pharm Corp Market Cap for the quarter ending March 03, 2018 was $242m a 8.27% increase of 20m year over year
  • Nymox Pharm Corp Price / Book for the quarter ending March 03, 2009 was 45.93 a -21.12% decrease of -9.70 year over year
  • Nymox Pharm Corp Enterprise Value for the quarter ending March 03, 2018 was $241m a 8.22% increase of 20m year over year
View Chart On Koyfin

Quarterly NYMX EV / EBITDA (ntm) Data

08/201344.48
08/201344.82
08/201343.96
08/201343.51
08/201345.62
08/201341.91
08/201340.20
08/201338.25
08/201338.20
08/201337.57

Annual NYMX EV / EBITDA (ntm) Data

201344.48
201344.82
201343.96
201343.51
201345.62
201341.91
201340.20
201338.25
201338.20
201337.57